#BEGIN_DRUGCARD DB00236

# AHFS_Codes:
Not Available

# ATC_Codes:
L01AX02

# Absorption:
Well absorbed from the GI tract.

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Amedel
Vercyte

# CAS_Registry_Number:
54-91-1

# ChEBI_ID:
Not Available

# Chemical_Formula:
C10H16Br2N2O2

# Chemical_IUPAC_Name:
3-bromo-1-[4-(3-bromopropanoyl)piperazin-1-yl]propan-1-one

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
An antineoplastic agent that acts by alkylation. [PubChem]

# Dosage_Forms:
Not Available

# Drug_Category:
Antineoplastic Agents
Antineoplastic Agents, Alkylating

# Drug_Interactions:
Acebutolol	Antagonism
Atenolol	Antagonism
Betaxolol	Antagonism
Bevantolol	Antagonism
Bisoprolol	Antagonism
Carteolol	Antagonism
Carvedilol	Antagonism
Esmolol	Antagonism
Labetalol	Antagonism
Metoprolol	Antagonism
Nadolol	Antagonism
Oxprenolol	Antagonism
Penbutolol	Antagonism
Pindolol	Antagonism
Practolol	Antagonism
Propranolol	Antagonism
Sotalol	Antagonism
Timolol	Antagonism

# Drug_Reference:
Not Available

# Drug_Type:
Approved
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
0.42

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
2490 mg/L

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Pipobroman

# HET_ID:
Not Available

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C10H16Br2N2O2/c11-3-1-9(15)13-5-7-14(8-6-13)10(16)2-4-12/h1-8H2

# InChI_Key:
InChIKey=NJBFOOCLYDNZJN-UHFFFAOYSA-N

# Indication:
For the treatment of polycythaemia vera and refractory chronic myeloid leukaemia.

# KEGG_Compound_ID:
C07362

# KEGG_Drug_ID:
D00467

# LIMS_Drug_ID:
236

# Mechanism_Of_Action:
The mechanism of action is uncertain but pipobroman is thought to alkylate DNA leading to disruption of DNA synthesis and eventual cell death.

# Melting_Point:
> 300 Â°C

# Molecular_Weight_Avg:
356.054

# Molecular_Weight_Mono:
353.95785306

# Organisms_Affected:
Humans and other mammals

# PDB_Experimental_ID:
Not Available

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
PA164747673

# Pharmacology:
Pipobroman is an antineoplastic agent. Specifically it is a piperazine derivative with a chemical structure close to that of many DNA alkylating agents. Pipobroman has well documented clinical activity against polycythemia vera and essential thrombocythemia.

# Predicted_LogP_Hydrophobicity:
1.09

# Predicted_LogS:
-2.2

# Predicted_Water_Solubility:
2.24e+00 g/l

# Primary_Accession_No:
DB00236

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
4842

# PubChem_Substance_ID:
46506548

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
APRD00693

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
BrCCC(=O)N1CCN(CC1)C(=O)CCBr

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Symptoms of overdose include hematologic toxicity, especially with chronic overdosage.

# Update_Date:
2013-02-08 16:19:11 -0700

# Wikipedia_Link:
http://en.wikipedia.org/wiki/Pipobroman

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Nucleus and mitochondria

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
14565648	Passamonti F, Lazzarino M: Treatment of polycythemia vera and essential thrombocythemia: the role of pipobroman. Leuk Lymphoma. 2003 Sep;44(9):1483-8.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
5556760	Yellin TO: Effects of piposulfan (Ancyte) on protein and DNA synthesis in Ehrlich ascites carcinoma. Life Sci II. 1971 Jun 8;10(11):605-12.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
Not Available

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
Not Available

# Drug_Target_1_Gene_Sequence:
>Example: Dickerson dodecamer
CGCGAATTCGCG

# Drug_Target_1_General_Function:
Biological information storage and information transfer

# Drug_Target_1_General_References:
1234	Nadeau D, Marchand C: Change in the kinetics of sulphacetamide tissue distribution in Walker tumor-bearing rats. Drug Metab Dispos. 1975 Nov-Dec;3(6):565-76.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
874

# Drug_Target_1_Locus:
All loci

# Drug_Target_1_Molecular_Weight:
7656 (double strand)

# Drug_Target_1_Name:
DNA

# Drug_Target_1_Number_of_Residues:
0

# Drug_Target_1_PDB_ID:
1BNA

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
Not Available

# Drug_Target_1_Protein_Sequence:
Not Available

# Drug_Target_1_Reaction:
DNA + DNA polymerase + nNTP = 2 DNA + nNDP; DNA + RNA polymerase + NTP = mRNA + nNDP

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
DNA is the molecule of heredity, as it is responsible for the genetic propagation of most inherited traits. It is a polynucleic acid that carries genetic information on cell growth, division, and function. DNA consists of two long strands of nucleotides twisted into a double helix and held together by hydrogen bonds. The sequence of nucleotides determines hereditary characteristics. Each strand serves as the template for subsequent DNA replication and as a template for mRNA production, leading to protein synthesis via ribosomes.

# Drug_Target_1_SwissProt_ID:
Not Available

# Drug_Target_1_SwissProt_Name:
Not Available

# Drug_Target_1_Synonyms:
Deoxyribonucleic acid

# Drug_Target_1_Theoretical_pI:
Not Available

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB00236
